Phase II trial of everolimus with sorafenib for patients with differentiated thyroid cancer (DTC) who progress on sorafenib alone

被引：3
|
作者：
Brose, M. S. [1 ]
Troxel, A. B. [1 ]
Mamtani, R. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.tps263
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS263
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II study of everolimus (E) and sorafenib (S) in patients (PTS) with metastatic differentiated thyroid cancer who have progressed on sorafenib alone
    Brose, Marcia S.
    Troxel, Andrea B.
    Yarchoan, Mark
    Cohen, Aaron Benjamin
    Harlacker, Kathleen
    Dyanick, Nikolas A.
    Posey, Zakkiyya A.
    Makani, Ramkrishna
    Prajapati, Parna
    Zifchak, Larisa M.
    Grande, Carolyn
    Squillante, Christian Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Sorafenib for patients with differentiated thyroid cancer
    Lee, Hyo Jin
    Ryu, Hyewon
    Choi, Yoon Seok
    Song, Ik-Chan
    Yun, Hwan-Jung
    Jo, Deog-Yeon
    Kim, Samyong
    LANCET, 2015, 385 (9964): : 228 - 228
  • [3] Phase I trial of combination sorafenib and tipifarnib: The experience in advanced differentiated thyroid cancer (DTC) and medullary thyroid cancer (MTC)
    Cabanillas, M. E.
    Kurzrock, R.
    Sherman, S. I.
    Tsimberidou, A. M.
    Waguespack, S.
    Naing, A.
    Busaidy, N.
    Gagel, R.
    Wright, J. J.
    Hong, D. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Phase II trial of sorafenib in advanced thyroid cancer
    Gupta-Abramson, Vandana
    Troxel, Andrea B.
    Nellore, Anoma
    Puttaswamy, Kanchan
    Redlinger, Maryann
    Ransone, Kathy
    Mandel, Susan J.
    Flaherty, Keith T.
    Loevner, Laurie A.
    O'Dwyer, Peter J.
    Brose, Marcia S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (29) : 4714 - 4719
  • [5] Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
    Kloos, Richard T.
    Ringel, Matthew D.
    Knopp, Michael V.
    Hall, Nathan C.
    King, Mark
    Stevens, Robert
    Liang, Jiachao
    Wakely, Paul E., Jr.
    Vasko, Vasyl V.
    Saji, Motoyasu
    Rittenberry, Jennifer
    Wei, Lai
    Arbogast, Daria
    Collamore, Minden
    Wright, John J.
    Grever, Michael
    Shah, Manisha H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (10) : 1675 - 1684
  • [6] Phase II study of everolimus and sorafenib for the treatment of metastatic thyroid cancer
    Sherman, Eric Jeffrey
    Ho, Alan Loh
    Fury, Matthew G.
    Baxi, Shrujal S.
    Haque, Sofia
    Lipson, Brynna Lane
    Kurz, Sarah
    Fagin, James A.
    Pfister, David G.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Phase II trial of sorafenib in patients with advanced thyroid cancer.
    Keefe, S. M.
    Troxel, A. B.
    Rhee, S.
    Puttaswamy, K.
    O'Dwyer, P. J.
    Loevner, L. A.
    Mandel, S. J.
    Brose, M. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] RNAseq analysis of the sorafenib phase III DECISION trial in differentiated thyroid cancer (DTC): Correlation with clinical outcome.
    Capdevila, Jaume
    Garcia, Ignacio Matos
    Mancuso, Francesco M.
    Iglesias, Carmela
    Nuciforo, Paolo
    Zafon, Caries
    Palmer, Hector G.
    Ogbah, Zighereda
    Muinos, Laura
    Pena, Carol Elaine
    Brose, Marcia S.
    Schlumberger, Martin
    Vivancos, Ana
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Sorafenib in locally advanced or metastatic patients with radioactive iodine-refractory differentiated thyroid cancer (DTC): The phase III DECISION trial
    Bockisch, A.
    Brose, M. S.
    Nutting, C.
    Jarzab, B.
    Elisei, R.
    Siena, S.
    Bastholt, L.
    de la Fouchardiere, C.
    Pacini, F.
    Paschke, R.
    Shong, Y. K.
    Sherman, S. I.
    Smit, J. W.
    Chung, J. W.
    Kappeler, C.
    Molnar, I.
    Schlumberger, M.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2014, 122 (03)
  • [10] Combination of everolimus and sorafenib in the treatment of thyroid cancer: Update on phase II study
    Sherman, Eric Jeffrey
    Ho, Alan Loh
    Fury, Matthew G.
    Baxi, Shrujal S.
    Dunn, Lara
    Lee, Jennifer S.
    Lipson, Brynna Lane
    Pfister, David G.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345